Anti-Cancer Properties Found in Spicy Indian Pepper Plant

Long pepper (Piper longum) was first referenced in ancient Ayurvedic textbooks, in which medicinal and dietary uses were described thousands of years ago. Long pepper, commonly found in Indian markets, is used as a spice in some Indian, North African, Indonesian, and Malaysian foods, but is rarely used in European dishes.

Credit: UT Southwestern Medical Center

“We are hopeful that our structure will enable additional drug development efforts to improve the potency of PL for use in a wide range of cancer therapies,” said Dr. Kenneth Westover, Assistant Professor of Biochemistry and Radiation Oncology. “This research is a spectacular demonstration of the power of x-ray crystallography.”

The long pepper, a plant native to India, is found in southern India and southeast Asia. Although rare in European fare, it is commonly found in Indian stores and used as a spice or seasoning in stews and other dishes. It dates back thousands of years in the Indian subcontinent tied to Ayurveda, one of the world’s oldest medical systems, and was referred to by Hippocrates, the ancient Greek physician known as the father of medicine.

“This study illustrates the importance of examining and re-examining our theories. In this case we learned something fundamentally new about a 3,000-year-old medical claim using modern science,” said Dr. Westover.”

Dr. Westover’s lab used X-ray crystallography to create this molecular model of piperlongumine.

Credit: UT Southwestern Medical Center

Dr. Westover, a member of the Harold C. Simmons Comprehensive Cancer Center, used cutting edge technologies in UT Southwestern’s Structural Biology Core (SBC) – the University’s world-renowned facility for X-ray crystallography, to better understand the anticancer properties of PL. X-ray crystallography allows scientists to determine molecular structures that reveal how molecules interact with targets – in this case how PL interacts with GSTP1. Viewing the structures helps in developing drugs for those targets.

The study is published in the Journal of Biological Chemistry.

This work is supported by the V Foundation for Cancer Research, founded by ESPN and legendary basketball coach Jim Valvano, The Welch Foundation, and the Cancer Prevention and Research Institute of Texas.

Additional UT Southwestern researchers who contributed to the study include alumni of the Westover lab: Dr. Wayne Harshbarger, Dr. John Hunter and Dr. Durga Udayakumar. Current UT Southwestern scientists in the Departments of Radiation Oncology and Biochemistry include Dr. Deepak Gurbani, Dr. William Singer, Dr. Yan Liu, Dr. Lianbo Li and Dr. Sudershan Gondi.

The Harold C. Simmons Comprehensive Cancer Center is the only NCI-designated Comprehensive Cancer Center in North Texas and one of just 47 NCI-designated Comprehensive Cancer Centers in the nation. Simmons Cancer Center includes 13 major cancer care programs. In addition, the Center’s education and training programs support and develop the next generation of cancer researchers and clinicians. Simmons Cancer Center is among only 30 U.S. cancer research centers to be designated by the NCI as a National Clinical Trials Network Lead Academic Participating Site.

Contacts and sources:
UT Southwestern Medical Center